Aequus Pharmaceuticals Inc.
AQS.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.70K | 27.30K | 34.90K | 18.80K | 32.20K |
| Total Receivables | 59.20K | 64.60K | 40.50K | 48.30K | 87.60K |
| Inventory | 71.20K | 108.90K | 26.30K | 73.50K | 118.20K |
| Prepaid Expenses | 17.00K | 10.90K | 94.30K | 53.20K | 39.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 33.20K | 32.80K |
| Total Current Assets | 173.10K | 211.70K | 196.00K | 227.00K | 310.50K |
|
|
|||||
| Total Current Assets | 173.10K | 211.70K | 196.00K | 227.00K | 310.50K |
| Net Property, Plant & Equipment | -- | 0.00 | 360.20K | 408.10K | 427.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 173.10K | 211.70K | 556.20K | 635.10K | 737.50K |
|
|
|||||
| Total Accounts Payable | 621.40K | 549.90K | 377.60K | 333.50K | 254.20K |
| Total Accrued Expenses | 17.50K | 29.20K | 69.20K | 65.40K | 58.30K |
| Short-term Debt | 4.42M | 4.19M | 4.19M | 4.39M | 4.06M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 134.40K | 89.40K | 86.70K | 89.50K | 85.70K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.19M | 4.86M | 4.72M | 4.88M | 4.46M |
|
|
|||||
| Total Current Liabilities | 5.19M | 4.86M | 4.72M | 4.88M | 4.46M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 4.42M | 4.19M | 4.19M | 4.39M | 4.06M |
| Capital Leases | 311.50K | 295.60K | 318.90K | 363.60K | 381.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.51M | 5.16M | 5.04M | 5.24M | 4.84M |
|
|
|||||
| Common Stock & APIC | 17.59M | 16.69M | 16.67M | 17.76M | 17.53M |
| Retained Earnings | -26.15M | -24.70M | -24.23M | -25.64M | -24.86M |
| Treasury Stock & Other | 3.23M | 3.07M | 3.07M | 3.28M | 3.23M |
| Total Common Equity | -5.33M | -4.95M | -4.49M | -4.60M | -4.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.33M | -4.95M | -4.49M | -4.60M | -4.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.33M | -4.95M | -4.49M | -4.60M | -4.10M |
|
|
|||||